CCR5-Dependent Homing of T Regulatory Cells to the Tumor Microenvironment Contributes to Skin Squamous Cell Carcinoma Development

Squamous cell carcinoma (SCC) is one of the most common human cancers worldwide. Recent studies show that regulatory T cells (Treg) have a critical role in the modulation of an antitumor immune response, and consequently the SCC development. Because the accumulation of Tregs at the tumor site is, in part, due to selective recruitment through CCR5- and CCR5-associated chemokines, we investigated the role of CCR5 in the SCC development. Our findings showed that CCR5-deficient mice (CCR5KO) were efficient in controlling papilloma's incidence when compared with wild-type mice. Analysis of tumor lesions in wild-type (WT) and CCR5KO mice revealed that lack of CCR5 lead to significant reduction in frequency of Tregs and increased of CD4 T cells into the tumors. Moreover, the adoptive transfer of naturally occurring Tregs CD4+CD25+CCR5+, CD4+CD25−CCR5+ or CD8+CCR5+ conventional T cells to CCR5KO mice resulted in an increased papilloma incidence. Interestingly, adoptive transfer of WT CD4+CD25+CCR5+ cells to CCR5KO mice induced more undifferentiated SCC lesions, characterized by higher infiltration of macrophages and dendritic cells. In this study, we also demonstrated that Treg migration to the tumor microenvironment is mediated by CCR5, and these cells are promoting tumor growth via inhibition of antitumor cells such as cytotoxic CD8+ T cells. Our findings reinforce the therapeutic potential of CCR5 inhibition for cancer treatment, and indicate an attractive approach for SCC treatment. Mol Cancer Ther; 16(12); 2871–80. ©2017 AACR.

[1]  E. Elkord,et al.  Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting , 2016, Vaccines.

[2]  M. Levings,et al.  T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression. , 2016, The Journal of clinical investigation.

[3]  S. Leach,et al.  Emerging Strategies for Cancer Immunoprevention , 2015, Oncogene.

[4]  P. Allavena,et al.  The interaction of anticancer therapies with tumor-associated macrophages , 2015, The Journal of experimental medicine.

[5]  Elaine Fuchs,et al.  TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma , 2015, Cell.

[6]  K. Bennewith,et al.  Emerging roles of regulatory T cells in tumour progression and metastasis , 2014, Cancer and Metastasis Reviews.

[7]  G. Garlet,et al.  Inflammasome Activation Is Critical to the Protective Immune Response during Chemically Induced Squamous Cell Carcinoma , 2014, PloS one.

[8]  Steven F. Ziegler,et al.  FOXP3 and scurfy: how it all began , 2014, Nature Reviews Immunology.

[9]  G. Garlet,et al.  PD-1 blockage delays murine squamous cell carcinoma development. , 2014, Carcinogenesis.

[10]  Ido D. Weiss,et al.  Inflammation‐induced hepatocellular carcinoma is dependent on CCR5 in mice , 2013, Hepatology.

[11]  F. Mattei,et al.  The Tumor Microenvironment: A Pitch for Multiple Players , 2013, Front. Oncol..

[12]  M. Maracy,et al.  CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients , 2013, Advanced biomedical research.

[13]  A. Cerwenka,et al.  Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth , 2012, The Journal of Immunology.

[14]  D. Kim,et al.  Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model. , 2012, Carcinogenesis.

[15]  Zhi-ren Zhang,et al.  Macrophages in Tumor Microenvironments and the Progression of Tumors , 2012, Clinical & developmental immunology.

[16]  G. Garlet,et al.  CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses. , 2012, Carcinogenesis.

[17]  J. Lafaille,et al.  Induced CD4+Foxp3+ regulatory T cells in immune tolerance. , 2012, Annual review of immunology.

[18]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[19]  C. Elmets,et al.  IL-17 Mediated Inflammation Promotes Tumor Growth and Progression in the Skin , 2012, PloS one.

[20]  Kendra M. Haney,et al.  Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents. , 2010, Bioorganic & medicinal chemistry letters.

[21]  G. Garlet,et al.  Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironment , 2010, Cancer Immunology, Immunotherapy.

[22]  Loise M. Francisco,et al.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells , 2009, The Journal of experimental medicine.

[23]  K. Matsushima,et al.  CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. , 2009, Journal of immunology.

[24]  S. Rosenberg,et al.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.

[25]  A. Rudensky,et al.  Control of regulatory T cell lineage commitment and maintenance. , 2009, Immunity.

[26]  M. Tretiakova,et al.  Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. , 2009, Cancer research.

[27]  J. Blay,et al.  Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. , 2009, Cancer research.

[28]  T. Eberlein,et al.  Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer1 , 2009, The Journal of Immunology.

[29]  K. Odunsi,et al.  Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[30]  David L. Woodland,et al.  The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. , 2008, Immunity.

[31]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[32]  M. Rossi,et al.  CCR5-Dependent Regulatory T Cell Migration Mediates Fungal Survival and Severe Immunosuppression1 , 2008, The Journal of Immunology.

[33]  S. John,et al.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.

[34]  I. Sobhani,et al.  High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas , 2007, Gut.

[35]  Y. Belkaid,et al.  CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence , 2006, The Journal of experimental medicine.

[36]  S. Iida,et al.  Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege. , 2006, Cancer research.

[37]  H. von Boehmer,et al.  The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. , 2006, Seminars in cancer biology.

[38]  J. Serody,et al.  C-C chemokine receptor 5 on stromal cells promotes pulmonary metastasis. , 2005, Cancer research.

[39]  K. Knutson,et al.  Tumor antigen-specific T helper cells in cancer immunity and immunotherapy , 2005, Cancer Immunology, Immunotherapy.

[40]  A. Houghton,et al.  Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells , 2004, The Journal of experimental medicine.

[41]  P. Allavena,et al.  Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. , 2004, European journal of cancer.

[42]  F. Balkwill,et al.  A chemokine receptor antagonist inhibits experimental breast tumor growth. , 2003, Cancer research.

[43]  C. Yee,et al.  Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation , 2002, Nature.

[44]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[45]  Varuna Aluvihare,et al.  B cells and professional APCs recruit regulatory T cells via CCL4 , 2001, Nature Immunology.

[46]  C. Figdor,et al.  Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? , 2012, The Lancet. Oncology.

[47]  Shannon C Miller,et al.  CCR5 plays a key role in the early memory CD8 + T cell response to respiratory virus infections , 2008 .

[48]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.